Professional Documents
Culture Documents
What do you do for someone who has delusions, hears treat diabetes—to induce comas in people suffering from
his dead uncle’s voice, or can’t communicate complete schizophrenia. Insulin coma therapy was thought for a
thoughts? The search for help has taken many paths. In the time to be helpful, but closer examination showed it car-
Western world today, treatment usually begins with one of ried great risk of serious illness and death. During this
the neuroleptic drugs invaluable in reducing the symptoms time, psychosurgery, including prefrontal lobotomies, was
of schizophrenia for many people. They are typically used introduced, and in the late 1930s, electroconvulsive therapy
with a variety of psychosocial treatments to reduce relapse, (ECT) was advanced as a treatment for schizophrenia. As
compensate for skills deficits, and improve cooperation with earlier drastic treatments, initial enthusiasm for ECT
for taking the medications (Cunningham Owens & faded because it was found not to be beneficial for most
Johnstone, 2012). people with schizophrenia—although it is still used with
a limited number of people today, sometimes in combi-
nation with antipsychotic medications (Zervas, Theleritis,
Biological Interventions & Soldatos, 2012). As we explained in Chapter 6, ECT is
Researchers have assumed for more than 100 years that sometimes recommended for people who experience severe
schizophrenia requires some form of biological interven- episodes of depression.
tion. Kraepelin, who so eloquently described dementia
praecox in the late 19th century, saw the disorder as a brain Antipsychotic Medications
disease. Lacking a biological treatment, he routinely rec-
A breakthrough in the treatment of schizophrenia came
ommended that the physician use “good patience, kindly
during the 1950s with the introduction of several drugs that
disposition, and self-control” to calm excited patients
relieved symptoms in many people (Cunningham Owens
(Nagel, 1991).
& Johnstone, 2012). Called neuroleptics (meaning “taking
During the 1930s, several novel biological treatments
hold of the nerves”), these medications provided the first
were tried. One approach was to inject massive doses of
real hope that help was available for people with schizo-
insulin—the drug that given in smaller doses is used to
phrenia. When they are effective, neuroleptics help people
think more clearly and reduce hallucinations and delu-
sions. They work by affecting the positive symptoms (delu-
sions, hallucinations, and agitation) and to a lesser extent
the negative and disorganized ones, such as social deficits.
Table 12.1 shows the classes of these drugs (based on their
chemical structure) and their trade names.
Recall from our discussion of the dopamine theory of
schizophrenia that the neuroleptics are dopamine antago-
nists. One of their major actions in the brain is to interfere
with the dopamine neurotransmitter system. They can also
affect other systems, however, such as the serotonergic and
glutamate system. We are just beginning to understand the
mechanisms by which these drugs work.
In general, each drug is effective with some people and
Bridgeman Art Library, London/SuperStock
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
luxuries by behaving appropriately. A patient could, for
example, buy cigarettes with the tokens he earned for keep-
ing his room neat. On the other hand, a patient would be
fined (lose tokens) for being disruptive or otherwise acting
inappropriately. This incentive system was combined with
a full schedule of daily activities. Paul and Lentz compared
the effectiveness of applied behavioral (or social learn-
ing) principles with traditional inpatient environments. In
general, they found that patients who went through their
Radius Images/Jupiter Images
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Collaborative psychopharmacology Using antipsychotic medications to treat the main symptoms of the disorder
(hallucinations, delusions), as well as using other medications for secondary
symptoms (for example, antidepressant medication for people with secondary
depression)
Assertive community treatment Providing support in the community, with emphasis on small caseloads for care
providers, services in the community setting rather than a clinic, and 24-hour
coverage
Family psychoeducation Assisting family members, including educating them about the disorder and its
management, helping them reduce stress and tension in the home, and pro-
viding social support
Supportive employment Providing sufficient support before and during employment so that the person
can find and keep a meaningful job
Illness management and recovery Helping the individual become an active participant in treatment, including
providing education about the disorder, teaching effective use of medication
strategies for collaborating with clinicians, and coping with symptoms when
they reoccur
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
DSM
S U M M A RY
Perspectives on Schizophrenia Clinical Description, Symptoms,
How is schizophrenia defined, and what symptoms are and Subtypes
included in its diagnosis?
What are the distinctions among positive, negative, and
c Schizophrenia is a complex syndrome that has been rec- disorganized symptoms of schizophrenia?
ognized for many years. Perhaps the earliest and best What are the clinical characteristics of schizophrenia
description of this disorder was published in 1809 by and other psychotic disorders?
John Haslam in his book Observations on Madness and
Melancholy. c Schizophrenia is characterized by a broad spectrum
c A number of historic figures during the 19th and early of cognitive and emotional dysfunctions that include
20th century contributed to the evolving definitions and delusions and hallucinations, disorganized speech and
possible causes of this spectrum of disorders. behavior, and inappropriate emotions.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Summary • 475
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Summary • 477
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
TREATMENT OF SCHIZOPHRENIA
Treatment
Individual, Group, and ■ Can help patient and family understand the disease and symptom triggers.
Family Therapy ■ Teaches families communication skills.
■ Provides resources for dealing with emotional and practical challenges.
Medications ■ Taking neuroleptic medications may help people with schizophrenia to:
—Clarify thinking and perceptions of reality
—Reduce hallucinations and delusions
■ Drug treatment must be consistent to be effective. Inconsistent dosage may
aggravate existing symptoms or create new ones.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203
Symptoms
Delusions ■ Unrealistic and bizarre beliefs not shared by others in the culture
Joshua Ets-Hokin/Photodisc/
■ May be delusions of grandeur (that you are really Mother Teresa or Napoleon) or
delusions of persecution (the cyclist who believed her competitors were sabotaging
her by putting pebbles in the road)
Getty Images
Hallucinations Sensory events that aren’t based on any external event (hearing voices, seeing
Photodisc/Getty Images
■
people who have died)
■ Many have auditory hallucinations (David hears his dead uncle talking to him)
■
■ Speaking in unintelligible words and sentences
Withdrawal ■ Lack of emotional response (flat speech, little change in facial expressions)
■ Apathy (little interest in day-to-day activities)
Photodisc/Getty Images
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.
Copyright 2019 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. WCN 02-200-203